drugset / Trial / NCT00141583

The Renin-Angiotensin System in Essential Hypertension

NCT00141583

Terminated 11 enrolled St George's, University of London
RandomizedCrossoverOpen-label

Summary

Although ACE Inhibitors and Angiotensin Receptor Blockers are effective blood pressure lowering agents, the exact mechanisms by which these agents lower BP are still not fully understood. This study aims to compare the blood pressure and hormonal responses (plasma renin activity and aldosterone) to the ACE inhibitor enalapril and ARB candesartan in individuals with mild essential hypertension.

Timeline

Start
2004-04
Primary completion
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan Unknown 8 mg
Subject Enalapril Other / unclassified 20 mg